While riding high on the popularity of its weight loss drug Zepbound, the company is quietly building a presence in a cutting ...

Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.

[Operator Instructions] Please be advised that today's conference is being recorded. This call will include a discussion of fourth quarter 2025 financial results and Gartner's outlook for 2026 as ...

Lilly will license programmable recombinases developed by Seamless to create new gene-editing therapies that could treat ...

Wave claimed GSK is handing back rights to the frontrunning program not because of questions about its potential, but because ...

Civitai—an online marketplace for buying and selling AI-generated content, backed by the venture capital firm Andreessen Horowitz—is letting users buy custom instruction files for generating celebrity ...

According to a report by Reuters, Eli Lilly and Company (NYSE:LLY) has signed an agreement worth up to $1.12 billion with ...

Some major former Atlus and Persona talent is working on a new game called Villion: Code, which is releasing in Japan later in 2026.

In this symposium, researchers will highlight how they overcome key obstacles between gene editing and clinical applications such as cell and gene therapy.

Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the buildup of a toxic protein that is a hallmark of Alzheimer's disease and ...

ARK Invest bought $10.4M in Joby Aviation stock after a 16.7% drop and sold Teradyne near highs on January 29, 2026. Full trade breakdown here.